An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor

被引：24
|
作者：
Reddy, Anumula Raghupathi [2 ]
Sampath, Alla [2 ]
Goverdhan, Gilla [2 ]
Yakambaram, Boja [2 ]
Mukkanti, Kagga [1 ,2 ]
Reddy, Padi Pratap [2 ]
机构：
[1] JNT Univ, Inst Sci & Technol, Ctr Environm Sci, Hyderabad 500072, Andhra Pradesh, India
[2] Dr Reddys Labs Ltd, Dept Res & Dev, Integrated Prod Dev, R R Dist 500072, AP, India
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2009年 / 13卷 / 01期
关键词：
COX-2; INHIBITORS; DERIVATIVES; PYRAZOLES; SC-58635;
D O I：
10.1021/op800158w
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
An improved, scalable and commercially viable process is developed for an active pharmaceutical ingredient, celecoxib.
引用
收藏
页码：98 / 101
页数：4
相关论文
共 50 条
  • [21] The Adverse Effect of Selective Cyclooxygenase-2 Inhibitor on Random Skin Flap Survival in Rats
    Ren, Haiyong
    Lin, Dingsheng
    Mou, Zhenyu
    Dong, Pu
    PLOS ONE, 2013, 8 (12):
  • [22] Selective inhibitors of cyclooxygenase-2
    Talley, JJ
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (01) : 55 - 62
  • [23] The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice
    Jacob, Shushan
    Laury-Kleintop, Lisa
    Lanza-Jacoby, Susan
    JOURNAL OF SURGICAL RESEARCH, 2008, 146 (01) : 135 - 142
  • [24] Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats
    Esquivias, Paula
    Morandeira, Antonio
    Escartin, Alfredo
    Cebrian, Carmelo
    Santander, Sonia
    Esteva, Francisco
    Asuncion Garcia-Gonzalez, Maria
    Ortego, Javier
    Lanas, Angel
    Piazuelo, Elena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4866 - 4874
  • [25] The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
    Caiazzo, Elisabetta
    Ialenti, Armando
    Cicala, Carla
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 848 : 105 - 111
  • [26] Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines
    Hashitani, S
    Urade, M
    Nishimura, N
    Maeda, T
    Takaoka, K
    Noguchi, K
    Sakurai, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (03) : 665 - 672
  • [27] [123I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
    Uddin, Md. Jashim
    Crews, Brenda C.
    Ghebreselasie, Kebreab
    Tantawy, Mohammed N.
    Marnett, Lawrence J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (02): : 160 - 164
  • [28] Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats
    Seo, Sang-Wan
    Lung, Won-Seok
    Piao, Tai-Guang
    Hong, Seung-Heon
    Yun, Ki-Jung
    Park, Rae-Kil
    Shin, Min-Kyo
    Song, Ho-Joon
    Park, Sung-Joo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (16) : 2298 - 2304
  • [29] Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats
    Vasquez-Bahena, D. A.
    Salazar-Morales, U. E.
    Ortiz, M. I.
    Castaneda-Hernandez, G.
    Troconiz, I. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (01) : 176 - 187
  • [30] MODULATION OF IONIZING RADIATION-INDUCED G2 ARREST BY CYCLOOXYGENASE-2 AND ITS INHIBITOR CELECOXIB
    Jun, Hyun Jung
    Kim, Young Mee
    Park, Soo Yeon
    Park, Ji Sun
    Lee, Eun Jung
    Choi, Shin Ae
    Pyo, Hongryull
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01): : 225 - 234
12345